Evidence map›Paper›PMID 36615964›Full record

ArticleNanomaterials (Basel, Switzerland)2022

ROS-Generating Hyaluronic Acid-Modified Zirconium Dioxide-Acetylacetonate Nanoparticles as a Theranostic Platform for the Treatment of Osteosarcoma.

Giovanna Chianese, Ines Fasolino, Chiara Tramontano, Luca De Stefano, Claudio Imparato, Antonio Aronne, Luigi Ambrosio, Maria Grazia Raucci, Ilaria Rea

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Giovanna ChianeseUnit of Naples, National Research Council, Institute of Applied Sciences and Intelligent Systems, 80131 Naples, Italy.ORCID 0000-0001-9037-5102
Ines FasolinoNational Research Council, Institute of Polymers, Composites and Biomaterials, 80131 Naples, Italy.ORCID 0000-0002-9568-3945
Chiara TramontanoUnit of Naples, National Research Council, Institute of Applied Sciences and Intelligent Systems, 80131 Naples, Italy.ORCID 0000-0003-1543-2327
Luca De StefanoUnit of Naples, National Research Council, Institute of Applied Sciences and Intelligent Systems, 80131 Naples, Italy.ORCID 0000-0002-9442-4175
Claudio ImparatoDepartment of Chemical, Materials and Production Engineering, University of Naples Federico II, 80125 Naples, Italy.ORCID 0000-0003-1725-7008
Antonio AronneDepartment of Chemical, Materials and Production Engineering, University of Naples Federico II, 80125 Naples, Italy.ORCID 0000-0002-2711-6789
Luigi AmbrosioNational Research Council, Institute of Polymers, Composites and Biomaterials, 80131 Naples, Italy.
Maria Grazia RaucciNational Research Council, Institute of Polymers, Composites and Biomaterials, 80131 Naples, Italy.ORCID 0000-0002-0516-4181
Ilaria ReaUnit of Naples, National Research Council, Institute of Applied Sciences and Intelligent Systems, 80131 Naples, Italy.ORCID 0000-0003-0568-9911
National Research Council · ITUniversity of Naples Federico II · IT

Funding

Ministry of Education, Universities and Research PRIN2017-ACTION, Grant No. 2017SZ5WZB
6 · The paper itself

Abstract

Materials that are able to produce free radicals have gained increasing attention for environmental and biomedical purposes. Free radicals, such as the superoxide anion (O

Indexed as

cancer therapyfunctionalizationhybrid zirconiananoparticlesosteosarcomaphotoluminescencereactive oxygen species

Identifiers

PMID36615964
PMCPMC9823868
OpenAlexW4312174135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.